A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Administration of LYN101 in Healthy Subjects and Multiple Administrations in Postmenopausal Women With Low Bone Mass
Latest Information Update: 22 Sep 2025
At a glance
- Drugs Osteoporosis therapies (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
Most Recent Events
- 22 Sep 2025 New trial record